72 results found.

Renal Cell Carcinoma Clinical Trial using everolimus and bevacizumab

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC).
everolimus and bevacizumab

Carcinoma, Renal Cell Clinical Trial using Sorafenib (Nexavar, BAY43-9006)

Bayer - Recruiting 18 years or older.
- Nexavar Dose Evaluation Study in Patients With Advanced Renal Cell Carcinoma.
Sorafenib (Nexavar, BAY43-9006)

Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, or Clinical Trial using cabozantinib-s-malate; sunitinib malate; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Randomized Phase II Study Comparing Cabozantinib With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma.
cabozantinib-s-malate; sunitinib malate; laboratory biomarker analysis

Solid Tumors, Triple-Negative Breast Cancer, Non Small Cell Lung Clinical Trial using CB-839

Calithera Biosciences, Inc - Recruiting 18 years or older.
- A Phase 1 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients With Advanced and/or Treatment-Refractory Solid Tumors.
CB-839

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of th Clinical Trial using eribulin mesylate; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I/II Study of E7389 Halichondrin B Analog (NSC # 707389) in Metastatic Urothelial Tract Cancer and Renal Insufficiency.
eribulin mesylate; laboratory biomarker analysis; pharmacological study

Kidney Cancer Clinical Trial using everolimus; placebo

Southwest Oncology Group - Recruiting 18 years or older.
- EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.
everolimus; placebo

Kidney Cancer Clinical Trial using Contrast Enhanced Intraoperative Ultrasound; DEFINITY; Phone Call

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Feasibility Study of Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy.
Contrast Enhanced Intraoperative Ultrasound; DEFINITY; Phone Call

Renal Cell Cancer Clinical Trial

VU University Medical Center - Recruiting 18 years or older.
- Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients.

Renal Cell Carcinoma, Breast Cancer, Colon Cancer, Lung Cancer, o Clinical Trial using dimethane sulfonate (DMS612, NSC 281612)

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase 1, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612) in Advanced Malignancies.
dimethane sulfonate (DMS612, NSC 281612)

Renal Cancer, or Von Hippel Lindau Clinical Trial using ZACTIMA (Vandetanib) (ZD6474)

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase 2 Study of ZD6474 (Vandetanib) in Patients With Von Hippel Lindau Disease and Renal Tumors.
ZACTIMA (Vandetanib) (ZD6474)

Syndrome Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer.

Renal Cell Carcinoma, Graft-Versus-Host Disease, or Engraftment S Clinical Trial using Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 75 years.
- Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma Using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells.
Pentostatin; Sirolimus; Cyclophosphamide; Allogeneic Hematopoietic Stem Cell Transplant; Th2 Cell Transplantation; Th2 Cells in Allogeneic HSCT

Metastatic Cancer, Metastatic Melanoma, Renal Cancer, Colorectal Clinical Trial using Anti-VEGFR2 CAR CD8 plus PBL; Cyclophosphamide; Aldesleukin; Fludarabine

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 66 years.
- Phase I/II Study of Metastatic Cancer Using Lymphodepleting Conditioning Followed by Infusion of Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes.
Anti-VEGFR2 CAR CD8 plus PBL; Cyclophosphamide; Aldesleukin; Fludarabine

Metastatic Melanoma, Metastatic Renal Cell Cancer, or Metastatic Clinical Trial using therapeutic autologous lymphocytes; aldesleukin; cyclophosphaide; fludarabine phosphate

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 66 years.
- Phase II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes.
therapeutic autologous lymphocytes; aldesleukin; cyclophosphaide; fludarabine phosphate

Renal Cell Carcinoma Clinical Trial using Bevacizumab; Ixempra (Ixbepilone [BMS-247550]

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- A Phase II Multi-Center Study of Bevacizumab in Combination With Ixabepilone in Subjects With Advanced Renal Cell Carcinoma.
Bevacizumab; Ixempra (Ixbepilone [BMS-247550]

Sarcoma, Endocrine Tumors, Neuroblastoma, Retinoblastoma, or Rena Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies.

Metastatic Renal Cell Cancer Clinical Trial using Everolimus

VU University Medical Center - Recruiting 18 years or older.
- Phase 1-2 Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer..
Everolimus

Neoplasms Clinical Trial using Regorafenib (Stivarga, BAY73-4506)

Bayer - Recruiting 18 years or older.
- A Phase I, Multi-center, Non-randomized, Open Label, Parallel-group Study Evaluating the Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Subjects With Severe Renal Impairment Compared to a Control Group.
Regorafenib (Stivarga, BAY73-4506)

Renal Cancer, or Renal Ischemia Clinical Trial using Off-clamp partial nephrectomy

Washington University School of Medicine - Recruiting 18 years or older.
- Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors.
Off-clamp partial nephrectomy

Renal Cell Carcinoma Clinical Trial using Arterial Spin Labeling Magnetic Resonance Imaging

Dana-Farber Cancer Institute - Recruiting 18 years or older.
- Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Antiangiogenic and Targeted Therapies of Metastatic Renal Cell Carcinoma.
Arterial Spin Labeling Magnetic Resonance Imaging

Clear Cell Renal Cell Carcinoma, or Stage IV Renal Cell Cancer Clinical Trial using entinostat; aldesleukin; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18; positron emission tomography; computed tomography

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination With the Histone Deacetylase Inhibitor Entinostat in Patients With Metastatic Renal Cell Carcinoma.
entinostat; aldesleukin; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18; positron emission tomography; computed tomography

Colorectal Cancers Clinical Trial using RENCA macrobeads

The Rogosin Institute - Recruiting 18 years or older.
- A Phase IIb, Nonrandomized, Open-Label Trial With Mouse Renal Adenocarcinoma (RENCA) Cell Containing Agarose-Agarose Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant, Metastatic Colorectal Carcinoma.
RENCA macrobeads

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Sta Clinical Trial using bevacizumab; anti-endoglin monoclonal antibody TRC105; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II Study of Bevacizumab Alone or in Combination With TRC 105 for Advanced Renal Cell Cancer.
bevacizumab; anti-endoglin monoclonal antibody TRC105; laboratory biomarker analysis; pharmacological study

Kidney Neoplasms Clinical Trial using Sunitinib malate; Placebo

Pfizer - Recruiting 18 years or older.
- Sunitinib Treatment Of Renal Adjuvant Cancer (S-TRAC): A Randomized Double Blind Phase 3 Study Of Adjuvant Sunitinib VS. Placebo In Subjects At High Risk Of Recurrent RCC.
Sunitinib malate; Placebo

Renal Impairment, Kidney Diseases, Urologic Diseases, Cancer, Hyp Clinical Trial using Renal hypothermia

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Randomized Controlled Trial of Renal Hypothermia During Partial Nephrectomy.
Renal hypothermia

Kidney Cancer Clinical Trial using stereotactic radiosurgery; Renal Biopsy; Serum Blood Markers

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- Evaluation of a Radio-Surgical Approach for the Treatment of Kidney Tumors in Poor Surgical Candidates.
stereotactic radiosurgery; Renal Biopsy; Serum Blood Markers

Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma, Papillary Clinical Trial using RAD001

Novartis - Recruiting 18 years or older.
- A Single Arm, Multicenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Cancer.
RAD001

Cancer of Kidney and Renal Pelvis, or Cancer of Liver Clinical Trial using Dexmedetomidine

Uppsala University Hospital - Recruiting 18 years to 80 years.
- Effects of Dexmedetomidine on Periprocedural Pain During Radiofrequency Ablation of Liver and Kidney Tumours.
Dexmedetomidine

Hepatic Complications, Renal Failure, or Unspecified Adult Solid Clinical Trial using dabrafenib; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 1 and Pharmacokinetic Study of Dabrafenib (GSK2118436B) in Patients With BRAFV600X Mutations and Renal or Hepatic Dysfunction.
dabrafenib; pharmacological study; laboratory biomarker analysis

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage Clinical Trial using pazopanib hydrochloride; therapeutic conventional surgery

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Pazopanib to Enable Partial Nephrectomy.
pazopanib hydrochloride; therapeutic conventional surgery

Pancreatic Cancer, or Colorectal Cancer Clinical Trial using Cancer macrobead placement in abdominal cavity

The Rogosin Institute - Recruiting 18 years or older.
- An Open-Label Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients With Treatment-Resistant, Metastatic Pancreatic or Colorectal Adenocarcinoma.
Cancer macrobead placement in abdominal cavity

Prostate Cancer Clinical Trial using Cancer Macrobead placement in abdominal cavity

The Rogosin Institute - Recruiting 18 years or older.
- An Open-Label, Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose- Agarose Macrobeads in the Treatment of Patients With Castration-Resistant Prostate Cancer Resistant to Docetaxel.
Cancer Macrobead placement in abdominal cavity

Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Ca Clinical Trial using Cisplatin; Gemcitabine; ALT-801

Altor Bioscience Corporation - Recruiting 18 years or older.
- A Phase Ib/II Trial of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer.
Cisplatin; Gemcitabine; ALT-801

Leiomyomatosis, or Kidney Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer.

Melanoma, Ovarian Cancer, Renal Cell Cancer, or Non-small Cell Lu Clinical Trial using IDC-G305

Immune Design - Recruiting 18 years to 80 years.
- A Phase 1 Open Label, Multicenter, Multiple Ascending Dose Trial Evaluating the Safety, Tolerability and Immunogenicity of Intramuscular Recombinant NY-ESO-1 Protein With GLA-SE Adjuvant in Patients With Unresectable or Metastatic Cancer.
IDC-G305

Renal Stones Clinical Trial using Escalating Energy SWL; Constant Energy SWL; Reduction Energy SWL

Princess Al-Johara Al-Ibrahim Cancer Research Center - Recruiting 30 years to 60 years.
- Comparison of Escalating, Constant and Reduction Energy Output in SWL for Renal Stones: Multi-arm Prospective Randomized Study..
Escalating Energy SWL; Constant Energy SWL; Reduction Energy SWL

Renal Cell Carcinoma Clinical Trial using BKM-120 Bevacizumab

Dana-Farber Cancer Institute - Recruiting 18 years or older.
- A Phase I Study of Bevacizumab and Escalation Doses of BKM-120 in Patients With Metastatic Renal Cell Carcinoma Who Failed Prior Systemic Therapies.
BKM-120 Bevacizumab

Kidney Cancer Clinical Trial using Contrast-enhanced Ultrasound; Perflutren lipid

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- LCCC 1219: A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced US in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy.
Contrast-enhanced Ultrasound; Perflutren lipid

Renal Cell Carcinoma Clinical Trial using CyberKnife. SBRT

Dana-Farber Cancer Institute - Recruiting 18 years or older.
- A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma.
CyberKnife. SBRT

Kidney Cancer Clinical Trial using aldesleukin; bevacizumab

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II Study of Bevacizumab and Aldesleukin in Patients With Metastatic Renal Cell Carcinoma (RCC): A Cytokine Working Group (CWG) Study.
aldesleukin; bevacizumab

Kidney Cancer Clinical Trial using sunitinib malate; gene expression analysis; reverse transcriptase-polymerase chain reaction; western blotting; immunohistochemistry staining method; laboratory biomarker analysis; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Biomarkers of Tumor Angiogenesis and Response to Sunitinib Maleate in Renal Cell Carcinoma.
sunitinib malate; gene expression analysis; reverse transcriptase-polymerase chain reaction; western blotting; immunohistochemistry staining method; laboratory biomarker analysis; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

Kidney Cancer Clinical Trial using motexafin gadolinium; sunitinib malate; comparative genomic hybridization; gene expression analysis; mutation analysis; polymorphism analysis; immunohistochemistry staining method; iodine I-124 girentuximab; laboratory biomarker analysis; pharmacological study; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Histopathologic and Imaging Study of Renal Cell Carcinoma Vasculature in the Setting of Sunitinib Therapy Prior to Cytoreductive Nephrectomy.
motexafin gadolinium; sunitinib malate; comparative genomic hybridization; gene expression analysis; mutation analysis; polymorphism analysis; immunohistochemistry staining method; iodine I-124 girentuximab; laboratory biomarker analysis; pharmacological study; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

Renal Cell Cancer Metastatic, or Kidney Cancer Metastatic Clinical Trial using Interleukin-2

Western Regional Medical Center - Recruiting 18 years or older.
- Phase II Trial of Moderate Dose Bolus Interleukin-2 in Metastatic Kidney Cancer.
Interleukin-2

Kidney Cancer Clinical Trial using Pazopanib; Temsirolimus; Quality of Life Assessment; Benadryl

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Randomized Phase 2 Trial of Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma.
Pazopanib; Temsirolimus; Quality of Life Assessment; Benadryl

Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, or Stage Clinical Trial using fluorescence imaging; laparoscopic surgery; indocyanine green

City of Hope Medical Center - Recruiting 18 years or older.
- A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors.
fluorescence imaging; laparoscopic surgery; indocyanine green

Renal Cancer Clinical Trial using 124IcG250

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma.
124IcG250

Kidney Cancer Clinical Trial using Bevacizumab; Temsirolimus

Hellenic Cooperative Oncology Group - Recruiting 18 years or older.
- Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Temsirolimus, After 1st Line Anti-VEGF Treatment in Patients With Advanced Renal Cancer.
Bevacizumab; Temsirolimus

Cancer, Congestive Heart Failure (CHF), Chronic Obstructive Pulmo Clinical Trial using Life Completion; Attention Control

Department of Veterans Affairs - Recruiting 18 years or older.
- Outlook: An Intervention to Improve Quality of Life in Serious Illness Study.
Life Completion; Attention Control

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Sta Clinical Trial using ziv-aflibercept; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase II Study to Determine the Effect of 2 Different Doses AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma.
ziv-aflibercept; laboratory biomarker analysis

Distal Urethral Cancer, Metastatic Transitional Cell Cancer of th Clinical Trial using gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma.
gemcitabine hydrochloride; cisplatin; placebo; bevacizumab; laboratory biomarker analysis

Advanced Solid Tumors, Kidney Disease, or Renal Impairment Clinical Trial using AMG 386 + Paclitaxel; AMG 386

Amgen - Recruiting 18 years or older.
- An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function.
AMG 386 + Paclitaxel; AMG 386

Kidney Cancer Clinical Trial using Pazopanib; Bevacizumab; Everolimus

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial.
Pazopanib; Bevacizumab; Everolimus

Lymphoma, Leukemia, Multiple Myeloma, Colon Cancer, or Renal Canc Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders.

Urothelial Cancer, Renal Pelvis Cancer, Ureter Cancer, or Bladder Clinical Trial using saliva sample and questionaire; saliva sample, questionaire

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- Familial and Atypical Urothelial Cancer Registry.
saliva sample and questionaire; saliva sample, questionaire

Metastatic Clear Cell Renal Cell Carcinoma Clinical Trial using IL-2; Stereotactic Ablative Body Radiation Therapy

University of Texas Southwestern Medical Center - Recruiting 18 years or older.
- A Phase II Trial of High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy (SABR) for Patients With Metastatic Clear Cell Renal Cell Cancer (mRCC).
IL-2; Stereotactic Ablative Body Radiation Therapy

Clear Cell, Metastatic Renal Cell Carcinoma Clinical Trial using Sunitinib

Sunnybrook Health Sciences Centre - Recruiting 18 years or older.
- A Phase II, Multi-Centre, Study of the Efficacy and Safety of Sunitinib Given on an Individualized Schedule as First-Line Therapy for Metastatic Renal Cell Cancer.
Sunitinib

Kidney Cancer Clinical Trial using Evaluation

M.D. Anderson Cancer Center - Recruiting N/A or older.
- A Phase II Metastasectomy Study for Patients With Renal Cell Carcinoma..
Evaluation

Recurrent Renal Cell Cancer, or Stage IV Renal Cell Cancer Clinical Trial using stereotactic body radiation therapy; therapeutic conventional surgery; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Immunologic Impact of Stereotactic Body Radiation Therapy (SBRT) in Renal Cell Carcinoma.
stereotactic body radiation therapy; therapeutic conventional surgery; laboratory biomarker analysis

Kidney Cancer Clinical Trial using gene expression analysis; protein expression analysis; diagnostic laboratory biomarker analysis; immunoenzyme technique; immunohistochemistry staining method

City of Hope Medical Center - Recruiting N/A or older.
- Development of a Blood Test of Anti-IMP3 Autoantibody for the Detection of Renal Cell Carcinoma With Metastasis and Metastatic Potential.
gene expression analysis; protein expression analysis; diagnostic laboratory biomarker analysis; immunoenzyme technique; immunohistochemistry staining method

Renal Cell Cancer Clinical Trial using Bevacizumab and Bortezomib

USC/Norris Comprehensive Cancer Center - Recruiting 18 years or older.
- .
Bevacizumab and Bortezomib

Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma Clinical Trial using laboratory biomarker analysis; cytology specimen collection procedure

Children's Oncology Group - Recruiting N/A to 29 years.
- Renal Tumors Classification, Biology, and Banking Study.
laboratory biomarker analysis; cytology specimen collection procedure

Kidney Cancer Clinical Trial using Voluven (Hydroxyethyl starch 130/0,4); Sodium Chloride 9mg/ml

Regional Hospital Holstebro - Recruiting 18 years or older.
- Effect of Hydroxyethyl Starch on Renal Handling of Salt and Water, Blood Pressure-regulating Hormones, Proteins and Circulatory System of Patients Undergoing Kidney Removal by Keyhole Surgery.
Voluven (Hydroxyethyl starch 130/0,4); Sodium Chloride 9mg/ml

Melanoma, Castrate Resistant Prostate Cancer, or Renal Cancer Clinical Trial using Naltrexone

Brown University - Recruiting 18 years or older.
- Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer: A Phase II Brown University Oncology Group Research Project.
Naltrexone

Metastatic Melanoma, or Renal Cell Cancer Clinical Trial using aldesleukin

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Studies on the Mechanism of Action of High-Dose IL-2 in Metastatic Melanoma and Renal Cell Cancer.
aldesleukin

Renal Cell Carcinoma Clinical Trial using sorafenib+gemcitabine+cisplatin

Beijing Cancer Hospital - Recruiting 18 years to 70 years.
- Sorafenib Combined With Cisplatin and Gemcitabine for the Treatment of Patients With Advanced Renal Collecting Duct Carcinoma:A Pilot, Open Study.
sorafenib+gemcitabine+cisplatin

Kidney Cancer Clinical Trial using everolimus

Baylor College of Medicine - Recruiting 18 years or older.
- Neoadjuvant Everolimus(RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01).
everolimus

Renal Cell Carcinoma Clinical Trial using Progressive strength training

German Cancer Research Center - Recruiting 18 years or older.
- Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Patients With Renal Cell Carcinoma Under Tyrosin Kinase Inhibitor Therapy.
Progressive strength training

Hepatocellular Cancer, Non-small Cell Lung Cancer, Renal Cell Can Clinical Trial using Avastin; Suntent; Nexavar

Medical University Innsbruck - Recruiting 18 years or older.
- Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients.
Avastin; Suntent; Nexavar

Renal Cell Carcinoma, Kidney Neoplasm, Renal Cancer, or Kidney Ca Clinical Trial using Yttrium-90 conjugated chimeric G250 (90Y-cG250)

Ludwig Institute for Cancer Research - Recruiting N/A or older.
- Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (90Y-DOTA-cG250) in Patients With Advanced Renal Cancer.
Yttrium-90 conjugated chimeric G250 (90Y-cG250)

Carcinoma, Renal Cell Clinical Trial using Radiofrequency ablation; Interferon-alpha; Radiofrequency ablation; Sunitinib maleate; Sunitinib maleate

Kidney Cancer Research Bureau - Recruiting 18 years to 85 years.
- Phase II Trial of Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients With Small Primary Tumor.
Radiofrequency ablation; Interferon-alpha; Radiofrequency ablation; Sunitinib maleate; Sunitinib maleate

Renal Cell Carcinoma Clinical Trial using Endurance exercise

Charite University, Berlin, Germany - Recruiting 18 years to 75 years.
- Effects of Physical Activity on the Endothelial and Cardiac Function of Patients With Renal Cell Carcinoma Receiving a Thyrosine Kinase Inhibitor (Sunitinib).
Endurance exercise

Kidney Cancer, or Metastatic Cancer Clinical Trial using sunitinib malate

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase II Study, Multicenter, Open-label, Evaluating Efficacy of Treatment With Sutentr (Sunitinib) in Patients With Previously Untreated or Recurrent Brain Metastases Originating From Renal Cancer.
sunitinib malate